CN Patent

CN103690960A — 甲磺酸洛美他派药物组合物及制备方法

Assigned to BEIJING KEYUAN CHUANGXIN TECHNOLOGY Co Ltd · Expires 2014-04-02 · 12y expired

What this patent protects

本发明公开了本发明公开了一种甲磺酸洛美他派药物组合物，其特征是该药物组合物由下列成分及百分比组成：20%-60%甲磺酸洛美他派，20%-50%无水乳糖、10-30%微晶纤维素、1%-10%交联聚乙烯吡咯烷酮、1%-10%泊洛沙姆、1%-5%微粉硅胶组成，该甲磺酸洛美他派药物组合物稳定性好，对提高产品收率，降低成本，实现产业化，更好的应用于临床，具有更明显的优势。

USPTO Abstract

本发明公开了本发明公开了一种甲磺酸洛美他派药物组合物，其特征是该药物组合物由下列成分及百分比组成：20%-60%甲磺酸洛美他派，20%-50%无水乳糖、10-30%微晶纤维素、1%-10%交联聚乙烯吡咯烷酮、1%-10%泊洛沙姆、1%-5%微粉硅胶组成，该甲磺酸洛美他派药物组合物稳定性好，对提高产品收率，降低成本，实现产业化，更好的应用于临床，具有更明显的优势。

Drugs covered by this patent

Patent Metadata

Patent number
CN103690960A
Jurisdiction
CN
Classification
—
Expires
2014-04-02
Drug substance claim
No
Drug product claim
No
Assignee
BEIJING KEYUAN CHUANGXIN TECHNOLOGY Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.